Tectonic Therapeutics
TECX • XNAS
Tectonic Therapeutics is a biological products, (no disgnostic substances) company trading on XNAS, led by CEO Alise S. Reicin, with a market cap of $519.0M.
Market Cap$519.0M
CEOAlise S. Reicin
CountryUnited States of America
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Next EarningsMay 7, 2026 · In 1 weekBefore Market Open · Q1 2026
Financials
Tectonic Therapeutics FAQ
Common questions about Tectonic Therapeutics
Tectonic Therapeutics is scheduled to report earnings for Q1 2026 on May 7, 2026 before market open.